Stay updated on ALN-TTRSC SubQ Clinical Trial

Sign up to get notified when there's something new on the ALN-TTRSC SubQ Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ALN-TTRSC SubQ Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    Major update: page now includes a government funding status notice and indicates version 3.2.0, replacing the previous 3.1.0.
    Difference
    6%
    Check dated 2025-10-05T10:21:46.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    Version updated from v3.0.2 to v3.1.0.
    Difference
    0.1%
    Check dated 2025-09-28T03:18:37.000Z thumbnail image
  5. Check
    37 days ago
    Change Detected
    Summary
    Updated the page from v3.0.1 to v3.0.2 and removed the Back to Top element, indicating a version bump with a minor UI cleanup.
    Difference
    0.4%
    Check dated 2025-09-13T17:41:30.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1.
    Difference
    0.4%
    Check dated 2025-09-06T15:26:01.000Z thumbnail image
  7. Check
    52 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of a facility name and location, as well as new drug information for Sodium Chloride and revusiran. The previous version's details about state, country, city, and certain medical conditions have been removed.
    Difference
    2%
    Check dated 2025-08-30T12:06:33.000Z thumbnail image
  8. Check
    66 days ago
    Change Detected
    Summary
    The web page has been updated from version v2.16.11 to v2.16.12.
    Difference
    0.1%
    Check dated 2025-08-16T04:40:56.000Z thumbnail image

Stay in the know with updates to ALN-TTRSC SubQ Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ALN-TTRSC SubQ Clinical Trial page.